Most cited papers from Hôpital André Mignot

Hôpital André Mignot

What are the most cited papers from Hôpital André Mignot?

The most cited paper from Hôpital André Mignot is "Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte" (Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste et al., 2010), with 1,589 citations. Next come "Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study" (1,016) and "A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism" (786).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 151 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste et al. · Blood Open access	15 Jun 2010	1,589
2	Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study Sylvie Castaigné et al. · The Lancet	Apr 2012	1,016
3	A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism Gérald Simonneau, Hervé Sors, Bernard Charbonnier et al. · New England Journal of Medicine Open access	4 Sep 1997	786
4	A PET Investigation of the Attribution of Intentions with a Nonverbal Task Éric Brunet-Gouet, Yves Sarfati, Marie‐Christine Hardy‐Baylé et al. · NeuroImage	Feb 2000	636
5	Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial Frédéric Peyrade et al. · The Lancet Oncology	9 Apr 2011	557
6	Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years Philippe H. Rousselot, Françoise Huguet, Delphine Réa et al. · Blood	14 Sep 2006	537
7	Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial Catherine Cordonnier, Cécile Pautas, Sébastien Maury et al. · Clinical Infectious Diseases	12 Mar 2009	391
8	Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine Raphaël Itzykson et al. · Blood	13 Oct 2010	388
9	Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure Virginie Lemiale et al. · JAMA	7 Oct 2015	386
10	Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia Yves Chalandon, Xavier Thomas, Sandrine Hayette et al. · Blood Open access	16 Apr 2015	381
11	Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia Éric Jourdan et al. · Blood	16 Jan 2013	362
12	Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation Rihab Nasr, Marie-Claude Guillemin, Omar Ferhi et al. · Nature Medicine	23 Nov 2008	352
13	Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study Adrienne de Labarthe, Philippe H. Rousselot, Françoise Huguet‐Rigal et al. · Blood Open access	24 Oct 2006	344
14	The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry Helen Jane Lachmann et al. · Annals of the Rheumatic Diseases Open access	22 Aug 2013	341
15	Potentially modifiable factors contributing to sepsis-associated encephalopathy Romain Sonneville, Étienne de Montmollin, Julien Poujade et al. · Intensive Care Medicine	2 May 2017	340
16	Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure Élie Azoulay et al. · JAMA Open access	25 Oct 2018	332
17	Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL Philippe H. Rousselot et al. · Blood Open access	28 Apr 2016	329
18	Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial Pierre Asfar et al. · The Lancet Respiratory Medicine	15 Feb 2017	311
19	Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure: Randomized Controlled Trial Élie Azoulay, Djamel Mokart, Jérôme Lambert et al. · American Journal of Respiratory and Critical Care Medicine	25 Jun 2010	309
20	Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study Nicolas Delanoy et al. · The Lancet Haematology	4 Dec 2018	301
21	Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial Stèphane Gaudry et al. · The Lancet Open access	Apr 2021	285
22	Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study Élie Azoulay et al. · American Journal of Respiratory and Critical Care Medicine Open access	31 Aug 2020	279
23	Islet-reactive CD8 + T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors Slobodan Čulina et al. · Science Immunology Open access	8 Feb 2018	271
24	Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists Stéphane Prost, Francis Relouzat, Marc Spentchian et al. · Nature Open access	Sep 2015	269
25	Causes for failure of ACL reconstruction and influence of meniscectomies after revision Christophe Trojani, Abderahmane Sbihi, Patrick Djian et al. · Knee Surgery Sports Traumatology Arthroscopy	19 Jul 2010	250
26	The World Cancer Report and the burden of oral cancer Michele Davide Mignogna, Stefano Fedele, Lucio Lo Russo · European Journal of Cancer Prevention	Apr 2004	239
27	Acute Neurological Involvement in Diarrhea-Associated Hemolytic Uremic Syndrome Sylvie Nathanson, Thérèsa Kwon, Monique Elmaleh et al. · Clinical Journal of the American Society of Nephrology Open access	24 May 2010	229
28	Managing critically Ill hematology patients: Time to think differently Élie Azoulay, Frédéric Pène, Michaël Darmon et al. · Blood Reviews	26 Apr 2015	228
29	Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors Sergio Gonzalez-Duque et al. · Cell Metabolism Open access	2 Aug 2018	225
30	Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure Djamel Mokart, Jérôme Lambert, David Schnell et al. · Leukemia & lymphoma/Leukemia and lymphoma	27 Nov 2012	223
31	Definition and epidemiology of mild traumatic brain injury C. Lefèvre-Dognin, Mélanie Cogné, Valérie Perdrieau et al. · Neurochirurgie Open access	6 May 2020	222
32	Mevalonate Kinase Deficiency: A Survey of 50 Patients Brigitte Bader‐Meunier et al. · PEDIATRICS	28 Jun 2011	220
33	PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study Olivier Casasnovas et al. · The Lancet Oncology Open access	15 Jan 2019	217
34	The Clinical Spectrum of Severe Imported Falciparum Malaria in the Intensive Care Unit: Report of 188 Cases in Adults Fabrice Bruneel, Laurent Hocqueloux, Corinne Alberti et al. · American Journal of Respiratory and Critical Care Medicine	21 Feb 2003	211
35	Therapeutic management of uterine fibroid tumors: updated French guidelines Henri Marret, Xavier Fritel, Lobna Ouldamer et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology	29 Aug 2012	204
36	Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome Stéphane Legriel et al. · PLoS ONE Open access	14 Sep 2012	204
37	Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams Emmanuel Weiss et al. · Clinical Microbiology and Infection Open access	13 Apr 2015	200
38	Machine learning algorithms performed no better than regression models for prognostication in traumatic brain injury Benjamin Yaël Gravesteijn et al. · Journal of Clinical Epidemiology Open access246 authors	19 Mar 2020	198
39	Clostridium difficile Carriage in Healthy Infants in the Community: A Potential Reservoir for Pathogenic Strains Clotilde Rousseau, Isabelle Poilane, Loïc de Pontual et al. · Clinical Infectious Diseases Open access	25 Jul 2012	198
40	Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study Neil P. Shah, François Guilhot, Jörge E. Cortes et al. · Blood Open access	26 Feb 2014	198
41	Abnormalities of brain function during a nonverbal theory of mind task in schizophrenia Éric Brunet-Gouet, Yves Sarfati, Marie‐Christine Hardy‐Baylé et al. · Neuropsychologia	2003	197
42	Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure Jean-François Timsit et al. · JAMA Open access	5 Oct 2016	195
43	Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest Bruno François et al. · New England Journal of Medicine Open access	6 Nov 2019	194
44	An International registry on Autoinflammatory diseases: the Eurofever experience Nataša Toplak et al. · Annals of the Rheumatic Diseases	Mar 2012	194
45	A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup Stéphanie Nguyen · Blood	15 May 2002	189
46	Intermittent Subglottic Secretion Drainage and Ventilator-associated Pneumonia: A Multicenter Trial Jean-Claude Lachérade, Bernard De Jonghe, Pierre Guezennec et al. · American Journal of Respiratory and Critical Care Medicine	3 Jun 2010	189
47	Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia Anne Bergeron, Delphine Réa, Vincent Lévy et al. · American Journal of Respiratory and Critical Care Medicine	28 Jun 2007	185
48	Revision ACL reconstruction: influence of a lateral tenodesis Christophe Trojani, Philippe Beaufils, Gilles Burdin et al. · Knee Surgery Sports Traumatology Arthroscopy	19 Nov 2011	184
49	Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034 Neil P. Shah, Philippe H. Rousselot, Charles Alan Schiffer et al. · American Journal of Hematology Open access	19 May 2016	183
50	Fertility after ectopic pregnancy: the DEMETER randomized trial Hervé Fernandez, P. Capmas, J.-P. Lucot et al. · Human Reproduction	12 Mar 2013	181

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.